Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

The Lancet

Volumn 345, Issue 8946, 1995, Pages 365-369

  Rn, A Gardulf ^a   Hammarström, L ^a   Gustafson, R ^a,b   Nyström, T ^a   Smith, C I Edvard ^a   Jonsson, E ^c,d   Gardulf, A ^a   Möller, G ^d,e   Björkander, J ^f   Ericson, D ^f   Andersen, V ^g   S o eberg, B ^g   Fr o land, S ^h   Jacobsen, M B ^h  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Infectious Diseases   (United Kingdom)

^c Department of Internal Medicine ^*  (United Kingdom)

^d Karolinska Institute Karolinska Hospital ^*  (United Kingdom)

^e KAROLINSKA INSTITUTE   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g Rigshospitalet   (Denmark)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BACKACHE; CHILL; CLINICAL TRIAL; DIARRHEA; DRUG COST; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTITUTION THERAPY; SWEDEN; TACHYCARDIA; THORAX PAIN; TISSUE REACTION; VERTIGO; WHEEZING;

EID: 0028857579     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90346-1     Document Type: Article

References (25)

1. Primary immunodeficiency diseases. Report of a WHO scientific group
2. Symptoms in patients with lowered levels of IgG subclasses, with or without IgA deficiency, and effects of immunoglobulin prophylaxis
3. Home intravenous immunoglobulin therapy by self-administration
4. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home
5. Immunoglobulin replacement therapy by self-infusion at home
6. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion
7. Immunoglobulin replacement therapy by slow subcutaneous infusion
8. Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin
9. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin
10. Subcutaneous gammaglobulin: effective management of hypogammaglobulinaemia
11. Subcutaneous immunoglobulin substitution in hypogammaglobulinemia
12. -1
13. Bio-availability of gammaglobulin after subcutaneous infusions in patients with common variable immunodeficiency
14. Subcutaneous infusion of gammaglobulins in management of agammaglobulinemia
15. Subcutaneous infusion of human standard globulin (HSG): clinical trial with two different dosages
16. Rapid subcutaneous immunoglobulin infusions in children
17. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.
18. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia
19. Subkutan gammaglobulin substitutuio X-hez kötött agammaglobulinaemiában
20. 1040 prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes
21. Itching for an explanation
22. Hepatitis C virus transmission by intravenous immunoglobulin
23. Intravenous immune globulin and acute aseptic meningitis
24. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events